224 related articles for article (PubMed ID: 2306514)
1. Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa.
Rao LV; Rapaport SI
Blood; 1990 Mar; 75(5):1069-73. PubMed ID: 2306514
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
3. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
4. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
5. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
Furukawa S; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
[TBL] [Abstract][Full Text] [Related]
7. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hoffman M; Monroe DM
Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of factor VIIa-catalyzed activation of factor VIII.
Soeda T; Nogami K; Matsumoto T; Ogiwara K; Shima M
J Thromb Haemost; 2010 Nov; 8(11):2494-503. PubMed ID: 20735721
[TBL] [Abstract][Full Text] [Related]
9. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.
Sutherland MR; Friedman HM; Pryzdial EL
Thromb Haemost; 2004 Nov; 92(5):947-55. PubMed ID: 15543320
[TBL] [Abstract][Full Text] [Related]
11. The role of proteolytic cleavage at Arg
Nakajima Y; Nogami K
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130501. PubMed ID: 37925034
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
[TBL] [Abstract][Full Text] [Related]
14. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.
Huang Q; Neuenschwander PF; Rezaie AR; Morrissey JH
J Biol Chem; 1996 Sep; 271(36):21752-7. PubMed ID: 8702971
[TBL] [Abstract][Full Text] [Related]
15. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa.
Fiore MM; Neuenschwander PF; Morrissey JH
J Biol Chem; 1994 Jan; 269(1):143-9. PubMed ID: 8276788
[TBL] [Abstract][Full Text] [Related]
16. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.
Neuenschwander PF; Morrissey JH
J Biol Chem; 1994 Mar; 269(11):8007-13. PubMed ID: 8132522
[TBL] [Abstract][Full Text] [Related]
17. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
[TBL] [Abstract][Full Text] [Related]
18. Factor VIIa and tissue factor--from cell biology to animal models.
Rao LV; Mackman N
Thromb Res; 2010 Apr; 125 Suppl 1():S1-3. PubMed ID: 20153022
[TBL] [Abstract][Full Text] [Related]
19. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
Beeler DL; Aird WC; Grant MA
J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
[TBL] [Abstract][Full Text] [Related]
20. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]